Top Markets
#1 aelf aelf +13.77%
#2 Status Status +10.16%
#3 TDCCP TDCCP +8.64%
#4 DAPPOS DAPPOS +7.72%
#5 Cryptopia Cryptopia +6.56%
#6 Tutorial Tutorial +5.79%
#7 HOME HOME +4.84%
#8 Nillion Nillion +4.55%
#9 Wrapped STX (Velar) Wrapped STX (Velar) +4.43%
#10 Mina Protocol Mina Protocol +4.40%
Coin of the day
aelf aelf
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Akums Drugs & Pharmaceuticals Ltd. Akums Drugs & Pharmaceuticals Ltd.

Akums Drugs & Pharmaceuticals Ltd.

AKUMS
Classifica tra le azioni #8292
Akums Drugs & Pharmaceuticals Ltd. is an Indian-based company, established in... Akums Drugs & Pharmaceuticals Ltd. is an Indian-based company, established in 2004 and headquartered in Delhi, that operates globally as a manufacturer and supplier of both finished pharmaceutical products and active pharmaceutical ingredients (APIs). Its diverse product range encompasses conventional drugs, traditional Ayurvedic and herbal remedies, personal care items including toiletries, nutraceuticals, food and dietary supplements, dermatological and cosmetic products, and healthcare and hospital supplies, along with over-the-counter (OTC) solutions. The company also deals in excipients and various chemical compounds. Akums develops and markets its own branded formulations across a variety of dosage forms, such as tablets, capsules, injectables, ophthalmic preparations, and soft gelatin capsules. These products address a broad spectrum of therapeutic areas, including gynaecology, cardiology, orthopaedics, pediatrics, dermatology, anti-infectives, pain management, and gastroenterology. Furthermore, Akums Drugs & Pharmaceuticals provides services as a pharmaceutical contract development and manufacturing organization (CDMO).
Prezzo delle azioni
$8.53
Ultima sincronizzazione: 2026-08-28
Capitalizzazione di mercato
$1.31B
Variazione (1 giorno)
1.50%
Variazione (1 anno)
65.49%
Paese
IN
Scambia Akums Drugs & Pharmaceuticals Ltd. (AKUMS)

Categoria

Healthcare
Ricavi di Akums Drugs & Pharmaceuticals Ltd. (AKUMS)
Ricavi nel Aug 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Akums Drugs & Pharmaceuticals Ltd., i ricavi attuali dell'azienda (TTM) sono pari a 0. Nel 2026, l'azienda ha registrato ricavi di 0 uguale a i ricavi dell'anno 2026, che erano pari a 0. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Akums Drugs & Pharmaceuticals Ltd. da 2026 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
Non abbastanza dati per le date fornite.
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.61B -
IN